Venture capital-backed Conatus falls after raising $66m via IPO

Venture capital-backed biotech company Conatus Pharmaceuticals raised $66m via an IPO on the dipped more than 10 per cent in its first day of trading on the Nasdaq exchange after raising $66m via its IPO.